Pregna International
Pregna International is a Mumbai-based medical device manufacturer, founded in 1991, of intrauterine contraceptive devices and hormonal intrauterine systems, distributed across 140+ countries through B2B/B2G channels serving hospitals, healthcare providers, and government family planning programs.
- Company typePrivate
- Founded1991
- HeadquartersMumbai, India
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Pregna International does
Pregna International Ltd., founded in 1991 and headquartered in Mumbai, India, is a privately held medical device manufacturer focused on women's reproductive health and contraception. The company's core technology is intrauterine contraception, spanning two families: (i) the Eloira levonorgestrel-releasing intrauterine system (IUS), a hormonal device with a 52mg hormone reservoir and rate-controlling membrane delivering approximately 20 mcg/day for up to five years and a claimed 99.8% effectiveness rate, and (ii) a broad copper-bearing IUD portfolio including Pregna Copper T 380A, the Inara series (Cu 375, Cu 375 Sleek, Cu 250), the Silverline silver-core series (Cu 380 Ag and Cu 200 Ag and mini variants), Copper Y Cu 380 and Mini, Safeload, Etherena, Pregna+, Aureline Gold, and Yanae. Beyond IUDs/IUS, Pregna offers tubal rings for female sterilization, a postpartum IUD (PPIUD), the CryoPop cryotherapy device, the Endometrial Biopsy Curette (EBC) and ancillary products (Esa uterine sound, UBT).
The company self-positions as the world's largest manufacturer of intrauterine contraceptive devices, with over 100 million IUDs sold cumulatively across 140+ countries. Revenue is generated via direct hardware sales through a sales-led, B2B/B2G go-to-market — selling to distributors, hospitals, healthcare systems, and government family planning programs — with multi-year procurement contracts and pricing by direct inquiry rather than published list pricing. End-customers are women of reproductive age served via physicians, gynecologists, hospitals, and public-sector family planning channels; Pregna supports demand with provider education, IEC catalog materials, and consumer/clinical content via its website and social channels. Ownership is founder/management-led with a minority growth investment from InvAscent's India Life Sciences Fund III (Rs 130 crore / ~$16M, June 2023).
Pregna International firmographics
Firmographics- Name
- Pregna International
- Legal name
- Pregna International Ltd.
- Website
- https://pregna.com
- Company type
- Private
- Founded year
- 1991
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Pregna International is a Mumbai-based medical device manufacturer, founded in 1991, of intrauterine contraceptive devices and hormonal intrauterine systems, distributed across 140+ countries through B2B/B2G channels serving hospitals, healthcare providers, and government family planning programs.
- Ownership category
- akta.pro rank
Pregna International industry classification
Industry- Product category
- Contraceptive Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Family Planning & Contraception (Including Abortion Care) (HLAKAJAG)
- akta.pro secondary industries
- Women’s Health & Reproductive Specialty Pharmaceuticals (HLAIACAN), Sexual & Reproductive Health (STI Care, Vulvovaginal Disorders) (HLAKAJAJ)
Keywords
Where Pregna International is headquartered
LocationHeadquarters
- HQ city
- Mumbai
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
Pregna International business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Medical Device Sales: Pregna International generates revenue primarily through the sale of intrauterine contraceptive devices and women's reproductive health products to healthcare providers, distributors, and institutional buyers globally.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | B2B/B2G institutional sales - pricing through direct inquiry |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Pregna International product offering
Product offeringCore offering
Pregna International manufactures and globally distributes a portfolio of intrauterine contraceptive devices, including hormonal intrauterine systems (Eloira levonorgestrel IUS), copper-based IUDs (Inara, Silverline, Copper T 380A, Copper Y, Pregna+, Etherena), postpartum IUDs, and tubal rings for female sterilization. The company also produces complementary gynecological devices such as CryoPop cryosurgical equipment and the Endometrial Biopsy Curette, sold to healthcare providers, hospitals, and public health programs across more than 140 countries.
Product overview
Pregna International is a global manufacturer of women's reproductive health solutions, offering a comprehensive portfolio of intrauterine devices and systems. The product portfolio includes two main categories: (1) Intrauterine Systems (IUS) - hormonal contraceptive devices like Eloira containing levonorgestrel hormone; and (2) Intrauterine Devices (IUD) - copper-based contraceptives including various models such as Safeload, Inara series (Cu 375, Cu 375 Sleek, Cu 250), Silverline series (Cu 380 Ag, Cu 200 Ag), Pregna Copper T 380A, Pregna+, Etherena, Copper Y devices, and Post Partum IUD. Additional offerings include Tubal Rings for female sterilization, CryoPop for cryosurgery, Endometrial Biopsy Curette (EBC), UBT, Aureline Gold IUD, and Yanae. The company positions itself as the world's largest IUD manufacturer with 100 million IUDs sold across 140 countries.
Differentiator
Problem solved
Functional benefit
Brands
- Eloira: Hormonal contraceptive intrauterine system (IUS) containing Levonorgestrel, marketed as a reversible contraceptive with 99.8% effectiveness rate.
- Inara
- Silverline
- Yanae
- Safeload
- Etherena
- CryoPop
Products and services
- Eloira Levonorgestrel Intrauterine System (IUS) Hormonal intrauterine system containing 52 mg levonorgestrel in a hormone reservoir with rate-controlling membrane; releases approximately 20 micrograms of levonorgestrel per day into the uterine cavity, effective for up to 5 years with a 99.8% effectiveness rate. Sold to healthcare providers and public health programs for long-term reversible contraception.
- Inara Cu 375 IUD Copper bearing intrauterine device providing long-term reversible contraception for women. Sold to healthcare providers and distributors globally.
- Inara Cu 375 Sleek IUD Slim profile variant of the Inara Cu 375 copper IUD designed for enhanced insertion comfort while providing long-term reversible contraception.
- Inara Cu 250 IUD Copper bearing IUD with lower copper surface area for long-term reversible contraception in women.
- Cu 250 Sleek IUD Slim profile copper intrauterine device for long-term reversible contraception.
- Silverline Cu 380 Ag IUD Long-term reversible intrauterine device with a silver core and copper surface, providing contraception for up to 10 years.
- Silverline Cu 200 Ag IUD Silver-core copper intrauterine device with moderate copper surface area for long-term reversible contraception.
- Silverline Cu 380 Ag Mini IUD Compact version of the Silverline silver-core copper IUD designed for women with smaller uterine cavities, providing long-term reversible contraception.
- Pregna Copper T 380A IUD T-shaped copper intrauterine device providing long-term reversible contraception for up to 10 years.
Quantifiable outcome
- 99.8% effectiveness rate for hormonal contraceptive (Eloira)
- +1 more outcomes
Companies that use Pregna International
Customer profileSegments2 records
Ideal customer profiles3 records
Pregna International technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Pregna International partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights5 records
Pregna International competitors and assessment
Company assessmentDirect peers
- CooperSurgical (PARAGARD): CooperSurgical markets PARAGARD, the leading copper IUD in the U.S., and offers a portfolio of OB/GYN devices and consumables. Directly competes with Pregna's copper IUD line (Copper T 380A, Inara, Silverline) for institutional tenders globally.
- DKT International: DKT International is one of the largest private providers of contraception and reproductive health products in the developing world, with manufacturing and distribution across 60+ countries. Directly comparable to Pregna as a contraceptive manufacturer-distributor targeting emerging-market family planning programs.
Broad incumbents
- Viatris (formerly Mylan): Viatris holds women's health assets including oral contraceptives and generic hormonal products with global distribution. Competes with Pregna in the broader contraceptive category, particularly on hormonal product lines targeting emerging markets.
- Organon: Spun out of Merck in 2021, Organon is a women's health-focused pharma with established contraceptive brands and global commercial reach. Competes with Pregna across hormonal contraception and family planning institutional channels.
- MSD (Merck & Co.) Women's Health: MSD operates a global women's health franchise including contraceptive implants (Implanon/Nexplanon) and IUDs. Competes with Pregna for OB/GYN share of voice and institutional family planning budgets.
- Teva Pharmaceutical Industries: Teva is a major generic pharmaceutical manufacturer with significant women's health and contraceptive offerings globally. Comparable as a broad incumbent competing for institutional family planning contracts.
- Bayer (Women's Health / Mirena): Bayer's Mirena, Kyleena, Liletta, and Skyla levonorgestrel IUS franchise is the global hormonal IUD market leader. Directly competes with Pregna's Eloira IUS on clinical positioning, prescriber relationships, and pricing in both developed and emerging markets.
Emerging players
- SMB Corporation (SMB Pharma / Fareva): SMB and similar Indian/Asian contract manufacturers produce generic IUDs and women's health devices for global brands. Comparable to Pregna on manufacturing capabilities and emerging-market distribution.
- Mona Lisa N.V. Mona Lisa is a Belgian manufacturer of copper IUDs with global distribution focus on family planning programs. Comparable to Pregna as a focused copper IUD manufacturer competing in the same institutional tender market.
Regional players
- HLL Lifecare Limited: HLL Lifecare is an Indian government-owned contraceptive and healthcare products manufacturer with a broad portfolio including condoms, IUDs, and blood bags. Comparable to Pregna as a domestic Indian manufacturer competing for public-sector family planning procurement, though with broader product scope.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Pregna International social profiles
Digital presencePregna International financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pregna International leadership team
Management profileNumber of profiles
Profiles1 record
Pregna International funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pregna International M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pregna International
What does Pregna International do?
Pregna International manufactures and globally distributes a portfolio of intrauterine contraceptive devices, including hormonal intrauterine systems (Eloira levonorgestrel IUS), copper-based IUDs (Inara, Silverline, Copper T 380A, Copper Y, Pregna+, Etherena), postpartum IUDs, and tubal rings for female sterilization. The company also produces complementary gynecological devices such as CryoPop cryosurgical equipment and the Endometrial Biopsy Curette, sold to healthcare providers, hospitals, and public health programs across more than 140 countries.
Is Pregna International a public or private company?
Pregna International is a private company. It is classified as venture growth investor backed and is currently operating.
When was Pregna International founded?
Pregna International was founded in 1991. It employs 51 to 100 people.
Where is Pregna International based?
Pregna International is headquartered in Mumbai, India, in the Asia region.
How does Pregna International make money?
One revenue line is on record: medical Device Sales.
Who are Pregna International's main competitors?
Direct peers on record are CooperSurgical (PARAGARD) and DKT International. Broad incumbents are Viatris (formerly Mylan), Organon, MSD (Merck & Co.) Women's Health, Teva Pharmaceutical Industries and Bayer (Women's Health / Mirena). Emerging players are SMB Corporation (SMB Pharma / Fareva) and Mona Lisa N.V.. HLL Lifecare Limited is listed as a regional player.
Does Pregna International have an API?
No public API is recorded for Pregna International.
What industry is Pregna International in?
Pregna International's product category is Contraceptive Medical Devices. Its primary akta.pro industry code is HLAKAJAG, Family Planning & Contraception (Including Abortion Care), with a secondary code of HLAIACAN, Women’s Health & Reproductive Specialty Pharmaceuticals. Its NAICS code is 339113 and its SIC code is 3841.